SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-026934
Filing Date
2021-02-24
Accepted
2021-02-23 18:50:59
Documents
3
Period of Report
2021-02-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm217716d1_8k.htm 8-K 22672
2 EXHIBIT 10.1 tm217716d1_ex10-1.htm EX-10.1 49675
3 GRAPHIC image_001.jpg GRAPHIC 3363
  Complete submission text file 0001104659-21-026934.txt   78467
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 21667538
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences